AI in Pharma Market Transforming Drug Discovery and Development with Artificial Intelligence

The drug discovery has become increasingly competitive and expensive, which has driven pharmaceutical companies to look into AI as a new method to reduce research and development costs, while avoiding costly errors. AI has a great potential to transform drug discovery by accelerating the research and development timeline, in an effort to make drugs affordable and improve the probability of FDA approval. This technology can also help with the repurposing new drugs, especially during the COVID-19 pandemic. AI and machine learning algorithms are able to identify molecules that may have failed in clinical trials and predict how the same compounds could be applied to target other diseases.

Request Sample Report at: https://www.alliedmarketresearch.com/request-toc-and-sample/13059

COVID-19 scenario Analysis:

► The emergence of COVID-19 pandemic has affected every industry except pharma industry across the world. Further, it is expected that growth of Pharma is mainly due to the companies resuming their operations and adapting to the new norm while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.

► The outbreak of COVID-19 pandemic has moderately inhibited the growth of pharma industries owing to financial impact, production and demand gap, or supply chain and market disruption.

► In addition, the artificial intelligence for drug discovery (pharma) and healthcare market have grown significantly.

► Furthermore, there are strong indications that the current pandemic has pushed the demand for technology and digital solutions. In the medium-to-long run the COVID-19 technology impact may be extremely positive. Everyone is forced to embrace new technologies and discover their benefits. Additional investments in digital infrastructure can be expected.

For Report Customization: https://www.alliedmarketresearch.com/request-for-customization/13059

Artificial intelligence (AI) technology integration in the drug discovery is steadily increasing, and many pharmaceutical companies are highly focusing on drug development using artificial intelligence. The pharmaceutical companies are taking advantage of artificial intelligence technology to discover the drugs for the most complex diseases such as precision's disease, Alzheimer's disease, and pancreatic cancer. Artificial intelligence helps the pharmaceutical companies to streamline the research and development activities for the personalized medicines and the complex drug discovery.

Key benefits of the report:

► This study presents the analytical depiction of the global AI in pharma market along with the current trends and future estimations to determine the imminent investment pockets.

► The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of global AI in pharma market share.

► The current market is quantitatively analyzed to highlight the global AI in pharma market growth scenario.

► Porter's five forces analysis illustrates the potency of buyers & suppliers in the AI in pharma industry.

► The report provides detailed global AI in pharma market analysis based on competitive intensity and how the competition will take shape in coming years.

Buy Now & Get Exclusive Discount: https://www.alliedmarketresearch.com/ai-in-pharma-market/purchase-options

Access the full summary at: https://www.alliedmarketresearch.com/ai-in-pharma-market-A12694

Artificial intelligence (AI) in pharma market consists of sales of AI in the pharma and related services that use an automated algorithm to perform tasks that traditionally rely on human intelligence. It can be used to handle data and present results that encourage better decision-making and save human efforts, cost, and time. The market consists of revenue generated by AI companies, which are applied in the pharmaceutical industry.

The increase in number of cross-industry collaborations and partnerships, along with the rise in requirement to control drug discovery & development costs, are the two significant factors that are responsible for the growth of the global artificial intelligence in the drug discovery market. Moreover, the surge in adoption of cloud-based applications and services and the impending patent expiry of blockbuster drugs further drive the growth of the AI in pharma market.

Key Market Players:

► Medtronic

► Cisco Systems

► Siemens

► IBM Corporation

► Johnson & Johnson.

► Biotronik

► Hill-Rom

► Atlas Wearables

► General Electronic company

► Philips

Inquiry Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/13059

Thanks for reading this article; you can also get individual chapter-wise sections or region-wise report versions like North America, Europe, or Asia.

If you have any special requirements, please let us know and we will offer you the report as per your requirements.

Lastly, this report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll-Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter

About us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies.

This helps us dig out market data that helps us generate accurate research data tables and confirm utmost accuracy in our market forecasting. Every data company in the domain is concerned. Our secondary data procurement methodology includes deep presented in the reports published by us is extracted through primary interviews with top officials from leading online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.